Raymond James Financial Services Advisors, Inc. Bristol Myers Squibb CO Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 671,223 shares of BMY stock, worth $36.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
671,223
Previous 664,061
1.08%
Holding current value
$36.2 Million
Previous $27.6 Million
25.95%
% of portfolio
0.05%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...